A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis

COVID-19 is a global pandemic associated with increased morbidity and mortality. Convalescent plasma (CP) infusion is a strategy of potential therapeutic benefit. We conducted a multicenter phase II study to evaluate the efficacy and safety of CP in patients with COVID-19, grade 4 or higher. To eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappa, Vasiliki, Bouchla, Anthi, Terpos, Evangelos, Thomopoulos, Thomas P., Rosati, Margherita, Stellas, Dimitris, Antoniadou, Anastasia, Mentis, Andreas, Papageorgiou, Sotirios G., Politou, Marianna, Kotanidou, Anastasia, Kalomenidis, Ioannis, Poulakou, Garyfalia, Jahaj, Edison, Korompoki, Eleni, Grigoropoulou, Sotiria, Hu, Xintao, Bear, Jenifer, Karaliota, Sevasti, Burns, Robert, Pagoni, Maria, Trontzas, Ioannis, Grouzi, Elisavet, Labropoulou, Stavroula, Stamoulis, Kostantinos, Bamias, Aristotelis, Tsiodras, Sotirios, Felber, Barbara K., Pavlakis, George N., Dimopoulos, Meletios- Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069820/
https://www.ncbi.nlm.nih.gov/pubmed/33920489
http://dx.doi.org/10.3390/microorganisms9040806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069820/
https://www.ncbi.nlm.nih.gov/pubmed/33920489
http://dx.doi.org/10.3390/microorganisms9040806

Ejemplares similares